Publications found:
73,128
Sort by:
Global Surgical Sinks Market Report 2020
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Surgical Sinks market size to maintain the average annual growth rate of XXX ... in the next few years, Surgical Sinks market size will be further expanded, we expect that by 2023, The market size of the Surgical Sinks will reach XXX million ...
September 2020
120 pages
Global Therapeutic Stents Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, Therapeutic Stents market size to maintain the average annual growth rate of XXX ... the next few years, Therapeutic Stents market size will be further expanded, we expect that by 2023, The market size of the Therapeutic Stents will reach XXX million ...
September 2020
118 pages
Global Thioamide Market Report 2020
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Thioamide market size to maintain the average annual growth rate of XXX from ... $ in 2018, BisReport analysts believe that in the next few years, Thioamide market size will be further expanded, we expect that by 2023, The ...
September 2020
117 pages
Global Third-Generation Sequencing Market Report 2020
US$ 2,350.00
... a relatively optimistic growth, the past four years, Third-Generation Sequencing market size to maintain the average annual growth rate of ... next few years, Third-Generation Sequencing market size will be further expanded, we expect that by 2023, The market size of the Third-Generation Sequencing will reach XXX ...
September 2020
115 pages
Global Transvaginal Endoscopy Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, Transvaginal Endoscopy market size to maintain the average annual growth rate of ... next few years, Transvaginal Endoscopy market size will be further expanded, we expect that by 2023, The market size of the Transvaginal Endoscopy will reach XXX ...
September 2020
124 pages
Global Color Sensors Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Color Sensors industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Color Sensors marke...
September 2020
121 pages
Global Anticancer Drug Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Anticancer Drug industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Anticancer Drug m...
September 2020
117 pages
Global Breast Imaging Equipments Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Breast Imaging Equipments industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Breast...
September 2020
117 pages
Global Geothermal Heat Pumps (GHPs) Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Geothermal Heat Pumps (GHPs) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Geot...
September 2020
116 pages
Global Humanized Mouse and Rat Model Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Humanized Mouse and Rat Model industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Hum...
September 2020
124 pages
Global Motion Preservation Devices Market Report 2020
US$ 2,350.00
With the slowdown in world economic growth, the Motion Preservation Devices industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Motio...
September 2020
124 pages
The Global Market for Wearable Technology in Healthcare
US$ 1,325.00
Wearable technology devices are increasingly being developed for the medical and healthcare markers, especially because of the growing number of patients overloading hospitals and medical centres. The...
September 2020
251 pages
Alzheimer's Disease - Pipeline Review, H2 2020
US$ 2,500.00
... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
1785 pages
Dyslipidemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
345 pages
Epilepsy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
662 pages
Atrial Fibrillation - Pipeline Review, H2 2020
US$ 2,000.00
... latest pipeline guide Atrial Fibrillation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Atrial Fibrillation (Cardiovascular) List of TablesNumber of Products under Development for Atrial Fibrillation, H2 2018 9Number of Products under Development ...
August 2020
134 pages
Duchenne Muscular Dystrophy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
413 pages
Genital Herpes - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
123 pages
Osteoarthritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
384 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
184 pages
Liver Cirrhosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
158 pages
Osteosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
868 pages
Anal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
589 pages
Bronchopulmonary Dysplasia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
81 pages
Restenosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
39 pages
Pulmonary Embolism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pulmonary Embolism (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
56 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
164 pages
Burns - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
111 pages
Pruritus - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
206 pages
Candidiasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
225 pages
Cough - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
116 pages
Diabetic Nephropathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
269 pages
Ocular Hypertension - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
145 pages
Oral Mucositis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
66 pages
Polycythemia Vera - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
132 pages
Blepharitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
63 pages
Fabry Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
126 pages
Grass Pollen Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
80 pages
Seborrhea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Seborrhea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Seborrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
50 pages
Diabetic Gastroparesis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
68 pages
Myocardial Ischemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
90 pages
Nasopharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
854 pages
Primary Immune Deficiency (PID) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Primary Immune Deficiency (PID) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Primary Immune Deficiency (PID) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
134 pages
Rectal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
245 pages
Cat Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cat Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cat Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
31 pages
Dementia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
537 pages
Thalassemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
215 pages
Leiomyosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
642 pages
